Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditions

Conclusions Anti-platelet drugs exert an immunomodulatory action by counteracting CD14highCD16+ monocyte increase under pro-inflammatory conditions, with this effect being dependent on the amplitude of P-selectin reduction.

http://cardiovascres.oxfordjournals.org/cgi/content/short/111/1/26?rss=1

Source: Cardiovascular Research - June 14, 2016 Category: Cardiology Authors: Layne, K., Di Giosia, P., Ferro, A., Passacquale, G. Tags: Integrative physiology and pathophysiology Source Type: research